The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern

C J Currie; J A Johnson

doi:10.1111/j.1463-1326.2011.01469.x

The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern

Diabetes Obes Metab. 2012 Jan;14(1):1-4. doi: 10.1111/j.1463-1326.2011.01469.x. Epub 2011 Nov 21.

Authors

C J Currie¹, J A Johnson

Affiliation

¹ School of Medicine, Cardiff University, Cardiff, UK. currie@cardiff.ac.uk

PMID: 21736688
DOI: 10.1111/j.1463-1326.2011.01469.x

Abstract

There is no doubt about the value of exogenous insulin for people with type 1 diabetes. The purpose of this commentary is to discuss emerging evidence that this may not be the case for the majority of people with type 2 diabetes.

Publication types

Review

MeSH terms

Diabetes Mellitus, Type 1 / drug therapy
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Angiopathies / blood
Diabetic Angiopathies / chemically induced*
Humans
Hypoglycemia / blood
Hypoglycemia / chemically induced*
Hypoglycemic Agents / administration & dosage
Hypoglycemic Agents / adverse effects*
Hypoglycemic Agents / blood
Insulin / administration & dosage
Insulin / adverse effects*
Insulin / blood
Risk Assessment

Substances

Hypoglycemic Agents
Insulin